Torrent Pharmaceuticals: Board Meeting Intimation for Financial Results For Quarter Ended 31-Dec-25 And Interim Dividend For The Year 2025-26.

Torrent Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on 31-Dec-25. The Board would also consider payment of Interim Dividend for the year 2025-26.